Free Trial
→ June 12: $100 Turns Into $100,000? (From Brownstone Research) (Ad)tc pixel Free IMCR Stock Alerts

Immunocore (IMCR) Short Interest Ratio & Short Volume

Immunocore logo
$27.79 -0.50 (-1.77%)
Closing price 04:00 PM Eastern
Extended Trading
$28.35 +0.56 (+2.02%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Immunocore Short Interest Overview

As of May 15, 2026, Immunocore (IMCR) had a short interest of 8.97 million shares sold short, representing 19.68% of the public float. This marks a 0.01% increase in short interest since the prior report. The short interest ratio (days to cover) is 35.4, meaning it would take 35.4 days of the average trading volume of 378,678 shares to cover all short positions.

Current Short Interest
8,970,345 shares
Previous Short Interest
8,969,565 shares
Change Vs. Previous Month
0.01%
Dollar Volume Sold Short
$251.62 million
Short Interest Ratio
35.4 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
50,690,000 shares
Short Percent of Float
19.68%
Today's Trading Volume
454,160 shares
Average Trading Volume
378,678 shares
Today's Volume Vs. Average
120%
Short Selling Immunocore?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Immunocore and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IMCR Short Interest Over Time

IMCR Days to Cover Over Time

IMCR Percentage of Float Shorted Over Time

Immunocore Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20268,970,345 shares $251.62 million +0.0%19.7%35.4 $28.05
4/30/20268,969,565 shares $250.34 million -8.3%19.7%20.81 $27.91
4/15/20269,781,949 shares $309.50 million -3.6%21.5%22.57 $31.64
3/31/202610,144,803 shares $305.87 million +0.1%22.3%26.05 $30.15
3/13/202610,137,184 shares $312.83 million -15.4%22.3%28.45 $30.86
2/27/202611,984,360 shares $387.09 million +5.5%26.5%31.43 $32.30
2/13/202611,360,037 shares $366.70 million +3.9%25.1%29.39 $32.28
1/30/202610,931,087 shares $355.81 million +9.1%24.1%17.53 $32.55
1/15/202610,015,378 shares $328.00 million +5.2%22.1%25.46 $32.75
12/31/20259,520,098 shares $330.44 million +5.2%21.0%36.58 $34.71
12/15/20259,052,969 shares $326.09 million +5.7%20.0%31.2 $36.02
11/28/20258,564,719 shares $338.01 million -2.3%18.9%22.05 $39.47
11/14/20258,767,994 shares $315.21 million +1.3%19.4%33.9 $35.95
10/31/20258,655,047 shares $286.40 million -0.1%19.2%31.74 $33.09
10/15/20258,660,000 shares $297.82 million +3.6%17.3%27.1 $34.39
9/30/20258,360,000 shares $303.72 million -3.8%16.7%28 $36.33
9/15/20258,690,000 shares $299.11 million -0.5%17.4%29.4 $34.42
8/31/20258,730,000 shares $281.28 million -0.9%17.5%25.8 $32.22
8/15/20258,810,000 shares $289.67 million +5.6%17.6%22.7 $32.88
7/31/20258,340,000 shares $273.30 million -1.2%17.1%20.7 $32.77
7/15/20258,440,000 shares $296.67 million -0.6%17.4%22.5 $35.15
6/30/20258,490,000 shares $266.42 million +1.6%17.5%21 $31.38
6/15/20258,360,000 shares $289.92 million +4.4%17.2%20 $34.68
5/31/20258,010,000 shares $292.28 million +0.8%16.5%19.4 $36.49
5/15/20257,950,000 shares $231.03 million No Change16.4%22.4 $29.06
4/30/20257,950,000 shares $239.30 million +3.5%16.3%25.3 $30.10
4/15/20257,680,000 shares $209.74 million -5.0%15.8%25.1 $27.31
3/31/20258,080,000 shares $239.73 million +6.5%16.6%26.7 $29.67
3/15/20257,590,000 shares $218.59 million +2.2%17.2%26.6 $28.80
2/28/20257,430,000 shares $218.22 million +0.1%16.8%28.2 $29.37
2/15/20257,420,000 shares $219.63 million +1.1%16.8%28.8 $29.60
1/31/20257,340,000 shares $241.34 million +9.4%15.1%27.8 $32.88
1/15/20256,710,000 shares $197.54 million -0.3%13.8%24.4 $29.44
12/31/20246,730,000 shares $198.54 million -4.7%13.8%24.7 $29.50
12/15/20247,060,000 shares $204.10 million -1.8%14.5%25.7 $28.91
11/30/20247,190,000 shares $235.40 million -5.4%14.8%25.9 $32.74
11/15/20247,600,000 shares $240.08 million -4.6%15.6%21.4 $31.59
10/31/20247,970,000 shares $245.72 million -4.3%16.4%21.6 $30.83
10/15/20248,330,000 shares $269.23 million -0.6%17.1%21.8 $32.32
9/30/20248,380,000 shares $260.87 million -1.0%17.2%20.8 $31.13
One page of the SpaceX S-1 will move this stock overnight (Ad)

When SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including power consumption for 1 million GPUs, a cost that rivals entire cities. That disclosure will name the supplier. One small, publicly traded power infrastructure company sits at the center of this - carrying a $1.5 billion backlog and priced like a utility. Dylan Jovine has the full breakdown.tc pixel

See the stock the S-1 revealed >>
9/15/20248,460,000 shares $283.83 million +23.0%17.4%19 $33.55
8/31/20246,880,000 shares $246.85 million +16.2%14.2%13.2 $35.88
8/15/20245,920,000 shares $217.56 million +9.0%12.2%8.6 $36.75
7/31/20245,430,000 shares $215.57 million -6.2%11.2%7.3 $39.70
7/15/20245,790,000 shares $228.53 million -1.4%12.0%7.6 $39.47
6/30/20245,870,000 shares $198.93 million -5.5%12.1%7.5 $33.89
6/15/20246,210,000 shares $238.84 million -7.0%12.8%8.3 $38.46
5/31/20246,680,000 shares $327.19 million +29.2%13.8%9.5 $48.98
5/15/20245,170,000 shares $289.57 million +13.1%10.7%8.9 $56.01
4/30/20244,570,000 shares $270.00 million +11.7%9.4%11.2 $59.08
4/15/20244,090,000 shares $227.16 million -11.3%8.4%8.2 $55.54
3/31/20244,610,000 shares $299.65 million +7.5%9.5%9.4 $65.00
3/15/20244,290,000 shares $260.96 million +1.4%8.8%8.9 $60.83
2/29/20244,230,000 shares $284.34 million +9.6%8.7%8.6 $67.22
2/15/20243,860,000 shares $272.13 million +20.6%8.0%8.2 $70.50
1/31/20243,200,000 shares $231.33 million +8.1%6.6%6.7 $72.29
1/15/20242,960,000 shares $211.82 million +2.4%6.1%8 $71.56
12/31/20232,890,000 shares $197.44 million -13.0%6.0%8.4 $68.32
12/15/20233,320,000 shares $213.04 million -17.2%6.9%10.1 $64.17
11/30/20234,010,000 shares $211.45 million -3.4%8.3%13.1 $52.73
11/15/20234,150,000 shares $198.95 million +12.5%8.6%15.4 $47.94
10/31/20233,690,000 shares $163.84 million +7.3%8.0%14.2 $44.40
10/15/20233,440,000 shares $172.65 million +4.6%7.4%15 $50.19
9/30/20233,290,000 shares $170.75 million +3.8%7.1%14.9 $51.90
9/15/20233,170,000 shares $167.34 million +6.0%6.9%15.1 $52.79
8/31/20232,990,000 shares $168.25 million +4.2%6.2%15.2 $56.27
8/15/20232,870,000 shares $172.92 million +8.3%6.0%14.2 $60.25
7/31/20232,650,000 shares $174.85 million -4.7%5.8%12.8 $65.98
7/15/20232,780,000 shares $176.25 million No Change6.1%12 $63.40
6/30/20232,780,000 shares $166.69 million -4.1%6.1%11.5 $59.96
6/15/20232,900,000 shares $168.03 million +7.8%6.4%11.3 $57.94
5/31/20232,690,000 shares $148.43 million -5.0%5.7%10.2 $55.18
5/15/20232,830,000 shares $174.44 million +14.6%6.0%10.8 $61.64
4/30/20232,470,000 shares $143.38 million -1.6%5.3%9.5 $58.05
4/15/20232,510,000 shares $137.57 million +0.4%5.3%9.7 $54.81
3/31/20232,500,000 shares $123.60 million +8.7%5.3%9.5 $49.44
3/15/20232,300,000 shares $121.12 million +10.1%4.9%8.6 $52.66
2/28/20232,090,000 shares $114.64 million No Change4.5%6.9 $54.85
2/15/20232,090,000 shares $134.87 million No Change4.5%6.3 $64.53
1/31/20232,090,000 shares $128.05 million +8.9%4.5%5.8 $61.27
1/15/20231,920,000 shares $122.00 million +39.1%4.1%4.9 $63.54
12/30/20221,380,000 shares $78.76 million -28.5%3.0%3.6 $57.07
12/15/20221,930,000 shares $114.68 million +27.0%4.1%5.2 $59.42
11/30/20221,520,000 shares $95.47 million -9.5%3.3%3.9 $62.81
11/15/20221,680,000 shares $109.33 million -15.6%3.6%4.4 $65.08
10/31/20221,990,000 shares $113.71 million -13.9%5.2%6 $57.14
10/15/20222,310,000 shares $111.76 million +6.9%6.1%7.8 $48.38
9/30/20222,160,000 shares $101.39 million +27.8%5.7%7.7 $46.94
9/15/20221,690,000 shares $76.17 million +89.5%4.4%5.7 $45.07
8/31/2022891,800 shares $47.10 million -1.2%2.3%3.1 $52.81
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
8/15/2022902,500 shares $49.42 million -15.7%2.4%4.3 $54.76
7/31/20221,070,000 shares $49.37 million No Change2.8%4.9 $46.14
7/15/20221,070,000 shares $46.28 million +4.9%2.8%5 $43.25
6/30/20221,020,000 shares $38.06 million -4.7%2.4%4.8 $37.31
6/15/20221,070,000 shares $32.37 million -21.3%2.5%5.3 $30.25
5/31/20221,360,000 shares $38.56 million +18.3%3.2%7 $28.35
5/15/20221,150,000 shares $33.74 million +31.6%2.7%6.2 $29.34
4/30/2022873,800 shares $28.49 million -0.1%2.0%5.5 $32.61
4/15/2022874,300 shares $30.64 million +2.5%2.0%5 $35.05
3/31/2022852,700 shares $25.50 million +4.0%2.0%4.9 $29.90
3/15/2022820,000 shares $20.25 million +9.1%1.9%5.6 $24.70
2/28/2022751,900 shares $16.62 million +5.1%1.8%5.6 $22.10
2/15/2022715,500 shares $17.64 million +64.7%1.7%5.7 $24.66
1/31/2022434,400 shares $9.80 million +17.7%1.0%3.6 $22.57
1/15/2022369,200 shares $8.47 million -5.0%N/A3.5 $22.95
12/31/2021388,700 shares $13.31 million +5.4%0.9%5.5 $34.24
12/15/2021368,700 shares $11.99 million +144.5%0.9%5.8 $32.51
11/30/2021150,800 shares $5.43 million -1.3%0.4%2.5 $35.99
11/15/2021152,800 shares $5.97 million -17.8%0.4%2.5 $39.10
10/29/2021185,800 shares $7.16 million +9.6%0.4%2.6 $38.52
10/15/2021169,500 shares $6.44 million -50.1%0.4%2.4 $38.00
9/30/2021339,500 shares $12.59 million +131.6%0.8%4.8 $37.07
9/15/2021146,600 shares $4.74 million -12.6%0.3%2.1 $32.31
8/31/2021167,700 shares $5.80 million -53.9%0.4%2.4 $34.56
8/13/2021363,500 shares $11.17 million No Change0.9%6.1 $30.72

IMCR Short Interest - Frequently Asked Questions

Short interest is the volume of Immunocore shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 8,970,345 shares of IMCR short. 19.68% of Immunocore's shares are currently sold short. Learn More on Immunocore's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMCR shares currently have a short interest ratio of 35.4. Learn More on Immunocore's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.68% of Immunocore's floating shares are currently sold short.

Immunocore saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,970,345 shares, an increase of 0.0% from the previous total of 8,969,565 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

19.68% of Immunocore's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Immunocore: Mirum Pharmaceuticals, Inc. (15.70%), TG Therapeutics, Inc. (20.55%), Belite Bio, Inc. Sponsored ADR (3.44%), CRISPR Therapeutics AG (29.57%), Grifols, S.A. (0.88%), Xenon Pharmaceuticals Inc. (4.13%), CG Oncology, Inc. (10.93%), Apogee Therapeutics Inc. (20.00%), Dianthus Therapeutics, Inc. (12.13%), Anbio Biotechnology (0.06%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling IMCR is an investing strategy that aims to generate trading profit from Immunocore as its price is falling. IMCR shares are trading down $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Immunocore occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMCR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMCR, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IMCR:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:IMCR) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
$36 million a day says something big is coming
Institutional capital is flowing into one thesis at a rate of $36 million per day - $25,000 every single minut...
Porter & Company | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Have you tried Elon Musk’s 70X AI agent?
Jeff Brown picked Nvidia in 2016 - it's up 25,155% since. He recommended Bitcoin at $240 - it's up 31,219% sin...
Brownstone Research | Sponsoredtc pixel
June 12th. After That, This Is Gone.
A small publicly traded company holds $9 billion in private SpaceX shares from a 2023 Starlink deal - and it's...
StocksToTrade | Sponsoredtc pixel